Lupin Limited has informed the Exchange regarding a press release dated April 22, 2026, titled "Lupin Launches Dapagliflozin and Metformin Hydrochloride Extended-Release Tablets in the United States".
Press Release Apr 22 2026
Filed with NSE ·
6ix hasn’t read this filing yet.
Earlier from Lupin
- Press Release Apr 10 2026
- Press Release Apr 08 2026
- Press Release Apr 07 2026
- Press Release Apr 02 2026
- Lupin Completes Acquisition of VISUfarma
Later from Lupin
- Press Release May 05 2026
- Lupin Receives U.S. FDA Approval for Glycerol Phenylbutyrate Oral Liquid
- Press Release May 07 2026
- Press Release May 13 2026
- Lupin Receives U.S. FDA Approval for Famotidine Injection, USP
Follow Lupin into a list and get an email when it puts out news.
Follow Lupin